4.7 Article

Synthesis and discovery of Baylis-Hillman adducts as potent and selective thioredoxin reductase inhibitors for cancer treatment

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Inhibition of thioredoxin reductase by natural anticancer candidate β-lapachone accounts for triggering redox activation-mediated HL-60 cell apoptosis

Junmin Zhang et al.

Summary: This study found that beta-Lapachone can selectively kill human promyelocytic leukemia HL-60 cells by inhibiting TrxR and increasing oxidative stress. Overexpression of TrxR reduced the effectiveness of beta-Lapachone, while knockdown of the enzyme increased its cytotoxicity. This discovery contributes to the understanding of the mechanism of action of beta-Lapachone and supports its potential as an anticancer drug candidate.

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Review Pharmacology & Pharmacy

Thioredoxin Reductase Inhibition for Cancer Therapy

Radosveta Gencheva et al.

Summary: Cytosolic selenoprotein thioredoxin reductase 1 (TrxR1) and mitochondrial TrxR2 (TXNRD2) can be inhibited by a wide range of electrophilic compounds, which may have important implications for cancer therapy.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2022)

Article Chemistry, Medicinal

Baylis-Hillman Adducts as a Versatile Module for ConstructingFluorogenic Release System

Lanning Zhao et al.

Summary: We report a versatile thiol-triggered fluorogenic release system that can rapidly release a molecule of interest and has been validated for its therapeutic potential in live cells and animal models.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Review Pharmacology & Pharmacy

Expanding the armory for treating lymphoma: Targeting redox cellular status through thioredoxin reductase inhibition

Sicong Wang et al.

Summary: This review discusses the upregulation of Nrf-2 regulated antioxidant systems in lymphomas and their association with multiple signaling pathways involved in lymphoma development and progression. Targeting antioxidant systems, especially TrxR, may represent a new therapeutic approach for lymphoma.

PHARMACOLOGICAL RESEARCH (2022)

Review Chemistry, Medicinal

Small molecules regulating reactive oxygen species homeostasis for cancer therapy

Junmin Zhang et al.

Summary: Regulating intracellular ROS levels may be an effective strategy for cancer prevention or treatment. This can be achieved through chemoprevention to reduce ROS production pathways, or through ROS-mediated anticancer therapy to stimulate ROS clearance, ultimately inhibiting tumor growth.

MEDICINAL RESEARCH REVIEWS (2021)

Article Biochemistry & Molecular Biology

Natural Molecules Targeting Thioredoxin System and Their Therapeutic Potential

Junmin Zhang et al.

Summary: The Thioredoxin (Trx) system plays a vital role in maintaining cellular redox homeostasis and regulating multiple cellular redox signaling pathways, and has been shown to be an important regulator in many diseases, especially tumorigenesis. Developing potential therapeutic molecules targeting this system is crucial for disease treatment.

ANTIOXIDANTS & REDOX SIGNALING (2021)

Review Biochemistry & Molecular Biology

Thioredoxin-dependent system. Application of inhibitors

Anna Jastrzab et al.

Summary: The thioredoxin-dependent system plays a crucial role in maintaining cellular redox homeostasis and regulating the expression of proteins through NF-κB or ASK-1 pathways. Research is ongoing to find compounds that can inhibit the activity of Trx and/or TrxR to modulate the progression of neoplastic processes.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Structural Modification of Aminophenylarsenoxides Generates Candidates for Leukemia Treatment via Thioredoxin Reductase Inhibition

Zi-Long Song et al.

Summary: The study prepared different amino-substituted phenylarsine oxides and found that the o-substituted molecule exhibited higher potency in inhibiting cellular TrxR activity, leading to oxidative stress-mediated apoptosis. These findings suggest the promising potential of TrxR inhibitors as cancer therapeutic agents.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Chemistry, Medicinal

Thioredoxin reductase inhibitors: updated patent review (2017-present)

Evgeny Chupakhin et al.

Summary: Thioredoxin reductase (TrxR) is a selenocysteine-containing enzyme responsible for maintaining redox balance in cells, with potential applications beyond cancer research. This review focuses on recent developments in TrxR inhibitors, including traditional classes and emerging nitro (hetero)aromatic compounds. While progress is slow, new approaches like Michael acceptors and dual compounds show promise, though the future of nitro (hetero)aromatic chemotypes remains uncertain.

EXPERT OPINION ON THERAPEUTIC PATENTS (2021)

Article Chemistry, Multidisciplinary

Tunable Methacrylamides for Covalent Ligand Directed Release Chemistry

Rambabu N. Reddi et al.

Summary: This study introduces a new class of alpha-substituted methacrylamides as potential electrophiles for targeted covalent inhibitors, showing higher thiol reactivity and undergoing a conjugated addition-elimination reaction. These electrophiles demonstrated comparable potency and improved selectivity in various assays, making them a versatile addition to the toolbox of targeted covalent inhibitor design.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

Review Biotechnology & Applied Microbiology

Targeting oxidative stress in disease: promise and limitations of antioxidant therapy

Henry Jay Forman et al.

Summary: Oxidative stress plays a role in various diseases, and understanding the mechanisms behind antioxidants and how to enhance antioxidant defences may lead to greater pharmacological success.

NATURE REVIEWS DRUG DISCOVERY (2021)

Review Pharmacology & Pharmacy

Thioredoxin reductase as a pharmacological target

Geir Bjorklund et al.

Summary: Thioredoxin reductases (TrxRs) are enzymes that reduce thioredoxin, playing a crucial role in the antioxidant system within cells. Inhibition of TrxR is a key clinical goal to address redox balance disturbances. Current research focuses on the importance of TrxRs in cellular functions and the mechanisms of inhibition by metal ions or chemicals.

PHARMACOLOGICAL RESEARCH (2021)

Article Biochemistry & Molecular Biology

The novel thioredoxin reductase inhibitor A-Z2 triggers intrinsic apoptosis and shows efficacy in the treatment of acute myeloid leukemia

Dongdong Zhang et al.

FREE RADICAL BIOLOGY AND MEDICINE (2020)

Review Chemistry, Multidisciplinary

The Thioredoxin System: A Promising Target for Cancer Drug Development

Hiba Ghareeb et al.

CHEMISTRY-A EUROPEAN JOURNAL (2020)

Article Chemistry, Inorganic & Nuclear

Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl2 Complexes

Dianna Truong et al.

INORGANIC CHEMISTRY (2020)

Article Multidisciplinary Sciences

Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell death

S. Busker et al.

SCIENCE ADVANCES (2020)

Review Cell Biology

Reactive oxygen species (ROS) as pleiotropic physiological signalling agents

Helmut Sies et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Article Chemistry, Multidisciplinary

A β-allyl carbamate fluorescent probe for vicinal dithiol proteins

Lanning Zhao et al.

CHEMICAL COMMUNICATIONS (2020)

Review Chemistry, Medicinal

Small molecule inhibitors of mammalian thioredoxin reductase as potential anticancer agents: An update

Junmin Zhang et al.

MEDICINAL RESEARCH REVIEWS (2019)

Review Biochemistry & Molecular Biology

Evolution of the thioredoxin system as a step enabling adaptation to oxidative stress

Monica Balsera et al.

FREE RADICAL BIOLOGY AND MEDICINE (2019)

Article Biochemistry & Molecular Biology

Promotion of HeLa cells apoptosis by cynaropicrin involving inhibition of thioredoxin reductase and induction of oxidative stress

Tianyu Liu et al.

FREE RADICAL BIOLOGY AND MEDICINE (2019)

Article Chemistry, Medicinal

Targeting the Thioredoxin System as a Strategy for Cancer Therapy

Mianli Bian et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Chemistry, Multidisciplinary

Site-selective protein conjugation at histidine

Karolina Peciak et al.

CHEMICAL SCIENCE (2019)

Review Biochemistry & Molecular Biology

Potential antioxidant activity of Morita-Baylis-Hillman adducts

Haitham Elleuch et al.

BIOORGANIC CHEMISTRY (2018)

Review Biochemistry & Molecular Biology

Selenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeutic

Xiaoyuan Ren et al.

FREE RADICAL BIOLOGY AND MEDICINE (2018)

Article Cell Biology

Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy

William C. Stafford et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Article Chemistry, Medicinal

Manumycin A Is a Potent Inhibitor of Mammalian Thioredoxin Reductase-1 (TrxR-1)

Anupama Tuladhar et al.

ACS MEDICINAL CHEMISTRY LETTERS (2018)

Review Chemistry, Multidisciplinary

Small Molecules to Target the Selenoprotein Thioredoxin Reductase

Baoxin Zhang et al.

CHEMISTRY-AN ASIAN JOURNAL (2018)

Review Pharmacology & Pharmacy

Targeting the Thioredoxin System for Cancer Therapy

Junmin Zhang et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2017)

Review Chemistry, Multidisciplinary

Chalcone: A Privileged Structure in Medicinal Chemistry

Chunlin Zhuang et al.

CHEMICAL REVIEWS (2017)

Review Chemistry, Multidisciplinary

Site-Selective Disulfide Modification of Proteins: Expanding Diversity beyond the Proteome

Seah Ling Kuan et al.

CHEMISTRY-A EUROPEAN JOURNAL (2016)

Article Chemistry, Multidisciplinary

Receptor selective ruthenium-somatostatin photosensitizer for cancer targeted photodynamic applications

Tao Wang et al.

CHEMICAL COMMUNICATIONS (2015)

Article Biochemical Research Methods

Bridging Disulfides for Stable and Defined Antibody Drug Conjugates

George Badescu et al.

BIOCONJUGATE CHEMISTRY (2014)

Review Biochemistry & Molecular Biology

The thioredoxin antioxidant system

Jun Lu et al.

FREE RADICAL BIOLOGY AND MEDICINE (2014)

Article Biochemistry & Molecular Biology

Shikonin targets cytosolic thioredoxin reductase to induce ROS-mediated apoptosis in human promyelocytic leukemia HL-60 cells

Dongzhu Duan et al.

FREE RADICAL BIOLOGY AND MEDICINE (2014)

Article Biochemistry & Molecular Biology

Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase

Dongzhu Duan et al.

FREE RADICAL BIOLOGY AND MEDICINE (2014)

Article Chemistry, Multidisciplinary

Highly Selective Off-On Fluorescent Probe for Imaging Thioredoxin Reductase in Living Cells

Liangwei Zhang et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)

Review Biochemistry & Molecular Biology

Principles in Redox Signaling: From Chemistry to Functional Significance

Alberto Bindoli et al.

ANTIOXIDANTS & REDOX SIGNALING (2013)

Review Biotechnology & Applied Microbiology

Modulation of oxidative stress as an anticancer strategy

Chiara Gorrini et al.

NATURE REVIEWS DRUG DISCOVERY (2013)

Review Biochemistry & Molecular Biology

Morita-Baylis-Hillman adducts: Biological activities and potentialities to the discovery of new cheaper drugs

Claudio G. Lima-Junior et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2012)

Article Chemistry, Medicinal

Studies toward Novel Peptidomimetic Inhibitors of Thioredoxin-Thioredoxin Reductase System

Szymon Klossowski et al.

JOURNAL OF MEDICINAL CHEMISTRY (2012)

Article Biochemistry & Molecular Biology

Chemistry and biology of reactive oxygen species in signaling or stress responses

Bryan C. Dickinson et al.

NATURE CHEMICAL BIOLOGY (2011)

Article Biochemistry & Molecular Biology

Thioredoxin and thioredoxin reductase: Current research with special reference to human disease

Arne Holmgren et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)

Review Chemistry, Multidisciplinary

Recent Contributions from the Baylis-Hillman Reaction to Organic Chemistry

Deevi Basavaiah et al.

CHEMICAL REVIEWS (2010)

Review Chemistry, Multidisciplinary

aza-Baylis-Hillman Reaction

Valerie Declerck et al.

CHEMICAL REVIEWS (2009)

Review Biotechnology & Applied Microbiology

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Dunyaporn Trachootham et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Article Biochemistry & Molecular Biology

Site-specific PEGylation of native disulfide bonds in therapeutic proteins

Sunil Shaunak et al.

NATURE CHEMICAL BIOLOGY (2006)

Article Chemistry, Multidisciplinary

Mechanism of the glutathione transferase-catalyzed conversion of antitumor 2-crotonyloxymethyl-2-cycloalkenones to GSH adducts

DS Hamilton et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)

Article Multidisciplinary Sciences

Structure and mechanism of mammalian thioredoxin reductase:: The active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence

LW Zhong et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)